Get the Stockscreener App
2.39
9.13%
0.20
After Hours:
2.28
-0.11
-4.60%
Alector Inc stock is traded at $2.39, with a volume of 987.08K.
It is up +9.13% in the last 24 hours and up +23.20% over the past month.
Alector Inc is a clinical-stage biopharmaceutical company. It is engaged in developing a novel therapeutic approach for the treatment of neurodegeneration. The firm is involved in developing therapies that are designed to simultaneously counteract pathologies by restoring healthy immune function to the brain. Its pipeline products include AL001, AL002, AL003, and AL101.
See More
Previous Close:
$2.19
Open:
$2.2
24h Volume:
987.08K
Relative Volume:
0.85
Market Cap:
$260.87M
Revenue:
$100.56M
Net Income/Loss:
$-119.05M
P/E Ratio:
-1.9431
EPS:
-1.23
Net Cash Flow:
$-231.16M
1W Performance:
+20.71%
1M Performance:
+23.20%
6M Performance:
+2.14%
1Y Performance:
+35.03%
1-Day Range:
$2.185
$2.425
1-Week Range:
$1.93
$2.425
52-Week Range:
$0.87
$3.3999
Alector Inc Stock (ALEC) Company Profile
Name
Alector Inc
Sector
Industry
Phone
415-231-5660
Address
131 OYSTER POINT BLVD., SUITE 600, SOUTH SAN FRANCISCO
Compare ALEC vs VRTX, REGN, ARGX, ALNY, ONC
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ALEC
Alector Inc
|
2.39 | 239.04M | 100.56M | -119.05M | -231.16M | -1.23 |
|
VRTX
Vertex Pharmaceuticals Inc
|
483.05 | 123.82B | 12.07B | 3.95B | 3.19B | 15.33 |
|
REGN
Regeneron Pharmaceuticals Inc
|
784.28 | 81.64B | 14.34B | 4.50B | 3.77B | 41.56 |
|
ARGX
Argen X Se Adr
|
816.95 | 52.00B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
327.36 | 44.14B | 3.71B | 313.75M | 465.38M | 2.2571 |
|
ONC
Beone Medicines Ltd Adr
|
352.23 | 40.83B | 4.98B | 69.60M | 525.67M | 0.5198 |
Alector Inc Stock (ALEC) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Oct-22-25 | Downgrade | BTIG Research | Buy → Neutral |
| Oct-22-25 | Downgrade | Cantor Fitzgerald | Overweight → Neutral |
| Oct-22-25 | Downgrade | Mizuho | Outperform → Neutral |
| Oct-22-25 | Downgrade | TD Cowen | Buy → Hold |
| Oct-22-25 | Downgrade | William Blair | Outperform → Mkt Perform |
| Jul-28-25 | Upgrade | Mizuho | Neutral → Outperform |
| Dec-17-24 | Downgrade | Mizuho | Outperform → Neutral |
| Dec-16-24 | Downgrade | Stifel | Buy → Hold |
| Dec-04-24 | Downgrade | BofA Securities | Neutral → Underperform |
| Nov-29-24 | Reiterated | H.C. Wainwright | Buy |
| Nov-26-24 | Downgrade | Morgan Stanley | Equal-Weight → Underweight |
| Dec-14-23 | Upgrade | Stifel | Hold → Buy |
| Dec-12-23 | Initiated | Deutsche Bank | Buy |
| Sep-25-23 | Initiated | Goldman | Sell |
| Sep-22-23 | Initiated | Cantor Fitzgerald | Overweight |
| Jan-06-23 | Downgrade | BofA Securities | Buy → Neutral |
| Sep-09-22 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Jul-07-22 | Initiated | Mizuho | Buy |
| Apr-13-22 | Initiated | Goldman | Sell |
| Mar-08-22 | Downgrade | Stifel | Buy → Hold |
| Sep-27-21 | Initiated | William Blair | Outperform |
| Jan-15-21 | Resumed | BofA Securities | Buy |
| Jun-24-20 | Initiated | H.C. Wainwright | Buy |
| Apr-28-20 | Initiated | Goldman | Buy |
| Mar-06-20 | Initiated | Citigroup | Buy |
| Feb-27-20 | Initiated | Barclays | Overweight |
| Feb-19-20 | Initiated | Stifel | Buy |
| Nov-21-19 | Initiated | BTIG Research | Buy |
| Mar-04-19 | Initiated | Barclays | Overweight |
| Mar-04-19 | Initiated | BofA/Merrill | Buy |
| Mar-04-19 | Initiated | Morgan Stanley | Overweight |
| Mar-04-19 | Initiated | SVB Leerink | Outperform |
View All
Alector Inc Stock (ALEC) Latest News
Alector: Q4 Earnings Snapshot - marketscreener.com
Alector (Nasdaq: ALEC) 2025 revenue drops as R&D falls and cash tops $256M - Stock Titan
Alector Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update - Yahoo Finance
Alector to Participate in the TD Cowen 46th Annual Health Care Conference - Bitget
Alector (NASDAQ:ALEC) Stock Rating Upgraded by Wall Street Zen - MarketBeat
Alector Inc expected to post a loss of 38 cents a shareEarnings Preview - TradingView
Alector, Inc. (NASDAQ:ALEC) Receives Average Recommendation of "Hold" from Brokerages - MarketBeat
Alector (ALEC) to Release Earnings on Wednesday - MarketBeat
What The New Sector Driven Price Target Means For Alector's Story And Valuation - Yahoo Finance
Why Alector Inc. stock could outperform in 2025CEO Change & AI Driven Stock Price Forecasts - mfd.ru
Is Alector Inc. stock a top pick in earnings seasonQuarterly Trade Report & Real-Time Chart Pattern Alerts - mfd.ru
What is Alector Inc.’s TAM (Total Addressable Market)Entry Point & AI Based Buy and Sell Signals - mfd.ru
What’s Alector Inc.’s historical returnJuly 2025 Sentiment & Capital Efficient Trading Techniques - mfd.ru
Why Alector Inc. stock is a must watch in 20252025 Geopolitical Influence & Reliable Intraday Trade Plans - mfd.ru
Should I add Alector Inc. stock to my portfolioJuly 2025 Selloffs & Weekly Setup with ROI Potential - mfd.ru
Trade Recap: Does FANG stock reflect fundamentalsWeekly Trade Report & Weekly Momentum Picks - baoquankhu1.vn
How The Narrative Around Alector (ALEC) Is Shifting After Index Removal And New Targets - Yahoo Finance
Aug Technicals: Is Alector Inc a cyclical or defensive stockWeekly Stock Recap & Free Risk Controlled Daily Trade Plans - baoquankhu1.vn
Legal Scrutiny Adds to Alector’s Clinical Setback Challenges - AD HOC NEWS
Panic Selling: Is NEXGEL Inc Equity Warrant benefiting from innovation trends2025 Technical Overview & Target Return Focused Picks - baoquankhu1.vn
INVESTOR ALERT: Levi & Korsinsky is Investigating Alec Stock After its Phase 3 INFRONT-3 Clinical Trial Misses Co-Primary Endpoint - Sahm
Levi & Korsinsky is Investigating Alec Stock After its Phase 3 INFRONT-3 Clinical Trial Misses Co-Primary Endpoint - marketscreener.com
Alector's Phase 3 Trial Results Fail to Meet Expectations - Intellectia AI
Risk Check: Is Alector Inc part of any ETFQuarterly Trade Summary & Entry Point Strategy Guides - baoquankhu1.vn
Alector, Inc. (NASDAQ:ALEC) Receives Average Recommendation of "Hold" from Analysts - MarketBeat
There's No Escaping Alector, Inc.'s (NASDAQ:ALEC) Muted Revenues Despite A 32% Share Price Rise - simplywall.st
Looking At The Narrative For Alector (ALEC) After Latozinemab Setback And Cost Cuts - Yahoo Finance
4 Next-Gen Candidates That Could Form the Future of Alzheimer’s Treatment - BioSpace
Take Profit: Is Alector Inc a strong growth stockWeekly Market Summary & AI Forecasted Stock Moves - baoquankhu1.vn
Price Action: Is Alector Inc stock positioned for digital transformationWeekly Trading Summary & AI Powered Market Entry Strategies - Bộ Nội Vụ
Aug PostEarnings: Will Alector Inc. (0Z2) stock profit from automation wave2025 Investor Takeaways & AI Forecast Swing Trade Picks - Bộ Nội Vụ
Merger Talk: Is BRKB showing insider buyingLayoff News & Real-Time Stock Entry Alerts - baoquankhu1.vn
Published on: 2026-01-11 01:48:35 - ulpravda.ru
How rising interest rates impact Alector Inc. stock2025 EndofYear Setup & Growth Focused Investment Plans - ulpravda.ru
What insider trading reveals about Alector Inc. stockRetail Investor Activity & Low Cost Stock Ideas - bollywoodhelpline.com
Will Alector Inc. (0Z2) stock profit from automation waveMarket Volume Summary & Technical Buy Zone Confirmation - ulpravda.ru
Guidance Update: How institutional buying supports Alector Inc. stockJuly 2025 Review & Free High Return Stock Watch Alerts - Улправда
How institutional buying supports Alector Inc. stockRecession Risk & Weekly Top Gainers Trade List - Улправда
Will Alector Inc. stock split again soonWeekly Trade Recap & AI Optimized Trading Strategy Guides - Улправда
Levi & Korsinsky Announces an Investigation on Behalf of Alector, Inc. (ALEC) Shareholders Who May Have Been Affected by Fraud - ACCESS Newswire
Alector (NASDAQ:ALEC) Stock Rating Upgraded by BTIG Research - MarketBeat
Alector : January 2026 Corporate Presentation - marketscreener.com
Rockford Register Star: Local News, Politics & Sports in Rockford, IL - FinancialContent
Alector, Inc. (ALEC) Investors with Losses are Urged to Contact Levi & Korsinsky to Discuss Their Rights - ACCESS Newswire
Setup Watch: Will Sound Group Inc Depositary Receipt stock see PE expansion2025 Technical Patterns & Smart Allocation Stock Tips - moha.gov.vn
ALEC ALERT: Levi & Korsinsky Reminds Investors of an Investigation Involving Possible Securities Fraud Violations by Alector, Inc. - ACCESS Newswire
Alector, Inc. (NASDAQ:ALEC) Given Average Rating of "Reduce" by Analysts - MarketBeat
Investors who lost money on Alector, Inc. should contact Levi & Korsinsky about an ongoing investigationALEC - ACCESS Newswire
Short Interest in Alector, Inc. (NASDAQ:ALEC) Expands By 35.9% - MarketBeat
Alector (NASDAQ:ALEC) Trading 4.8% HigherHere's Why - MarketBeat
Alector, Inc. Investigated Regarding Potential Securities Law ViolationsContact Levi & Korsinsky for DetailsALEC - ACCESS Newswire
Alector Inc Stock (ALEC) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.52%
1.68%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):